Browse

You are looking at 251 - 300 of 1,314 items for

  • Refine by Access: All content x
Clear All
Restricted access

PART I BASIC CONCEPTS AND TEST INTERPRETATIONS

Christopher J. Edwards and Brian L. Erstad

Restricted access
Cover Basic Skills in Interpreting Laboratory Data

Basic Skills in Interpreting Laboratory Data

Christopher J. Edwards and Brian L. Erstad

Restricted access

Benazepril Hydrochloride Suspension 2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Bethanechol Chloride Solution 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Bethanechol Chloride Suspension 5 mg/mL*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Buspirone Hydrochloride Syrup 2.5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Busulfan Syrup 2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Caffeine Citrate Solution 20 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

21 Cancers and Tumor Markers

Sarah A. Schmidt

Restricted access

Candesartan Cilexetil Suspension 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Captopril Solution 1 mg/mL*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Captopril Suspension 0.75 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Captopril Suspension 0.8 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Captopril Suspension 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

12 CARBAMAZEPINE

Jacquelyn L. Bainbridge, Pei Shieen Wong, Sarah N. Rajkovic, and Grace S. Chin

Restricted access

CH 1.6 Carbamazepine

John E. Murphy

Restricted access

CH 2.6 Carbamazepine

John E. Murphy

Restricted access

Carbamazepine Suspension 25 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Carbamazepine Syrup 40 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

7 Cardiac Function and Related Tests

Jessica DeAngelo and Jacqueline Finger

Restricted access

Carvedilol Suspension 0.1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Carvedilol Suspension 1.67 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Carvedilol Suspension 5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Cefazolin Sodium Ophthalmic Solution 33 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Celecoxib Suspension 10 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Celecoxib Suspension 10 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Chloroquine Phosphate Suspension 15 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Chloroquine Phosphate Suspension 15 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Chloroquine Phosphate Syrup 16.7 mg/mL*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Chlorpromazine Hydrochloride Syrup 100 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Cholecalciferol Suspension 50,000 units/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Cidofovir Intravitreous Solution 0.2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Cidofovir Intravitreous Solution 8.1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Cinacalcet Suspension 5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Ciprofloxacin Hydrochloride Suspension 50 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Ciprofloxacin Hydrochloride Suspension 50 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access
Cover Clinical Pharmacokinetics

Clinical Pharmacokinetics

John E. Murphy

Restricted access
Cover Clinical Pharmacokinetics Workbook

Clinical Pharmacokinetics Workbook

John E. Murphy

Restricted access

Clonazepam Suspension 0.1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Clonazepam Suspension 0.2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Clonidine Hydrochloride Suspension 0.01 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Clonidine Hydrochloride Syrup 0.02 mg/mL*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Clonidine Hydrochloride Syrup 0.1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Clopidogrel Bisulfate Suspension 5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Codeine Phosphate Syrup 3 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Commercially Available Products (Use Only if Commercially Unavailable)

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

7 CONSIDERATIONS FOR MEDICATION USE IN THE GERIATRIC PATIENT

Susan W. Miller

Restricted access

Cyclophosphamide Suspension 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Cyclosporine Suspension 100 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Dantrolene Sodium Syrup 5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes